Latest Earnings Analysis

• Digimarc (DMRC) Q1 2026: ARR Climbs 9% Sequentially as Retail Rollouts and Trust Platform Expand
  May 13, 2026 · DMRC
• AKA Brands (AKA) Q1 2026: Streetwear Margin Expands 180bps as Test-and-Repeat Drives Turnaround
  May 13, 2026 · AKA
• SunPower (SPWR) Q1 2026: Bookings Hit 4,446 as Cost Cuts Target Q3 Profitability
  May 13, 2026 · SPWR
• AMCO Pittsburgh (AP) Q1 2026: Air & Liquid Orders Surge 40% as FCEP Mix Headwinds Ease
  May 13, 2026 · AP
• STXS Q1 2026: MAGIC Catheter Ramp Targets $10M+ Quarterly Recurring Revenue Run Rate
  May 13, 2026 · STXS
• Stellis Capital (SCM) Q1 2026: Non-Accruals Rise to 9.2% of Cost as Dividend Reset Looms
  May 13, 2026 · SCM
• LightInTheBox (LITB) Q1 2026: Branded Apparel Jumps 81%, Now 24% of Revenue
  May 13, 2026 · LITB
• Organigram (OGI) Q2 2026: Sanity Group Adds €25M Quarterly Run Rate as International Shift Accelerates
  May 13, 2026 · OGI
• UPEXI (UPXI) Q3 2026: Solana Holdings Up 9% as Cost Base Nears Self-Sustaining Threshold
  May 13, 2026 · UPXI
• IPM (IPM) Q1 2026: Managed IT Services Up 19% as AI Partnerships Anchor Regulated Market Push
  May 13, 2026 · IPM
• IZEA (IZEA) Q1 2026: Enterprise Account Revenue per Client Jumps 33% as SMB Exit Completes
  May 13, 2026 · IZEA
• 5E Advanced Materials (FEAM) Q3 2026: First 7,500-Ton Offtake Deal Unlocks Commercialization Milestone
  May 13, 2026 · FEAM
• Lineage Cell Therapeutics (LCTX) Q1 2026: Alloscope Platform Drives Expansion, $53M Cash Extends Runway
  May 13, 2026 · LCTX
• Atea Pharmaceuticals (AVIR) Q1 2026: HCV Phase III Enrollment Reaches 95%, Securing Late-Stage Pipeline Momentum
  May 13, 2026 · AVIR
• Fractal (GUTS) Q1 2026: Pivotal Trial Progress Sets Up Three Data Catalysts Into Year-End
  May 13, 2026 · GUTS
• Kura Oncology (KURA) Q1 2026: ComSifty Captures 40% New Patient Share, Accelerating Class Leadership
  May 13, 2026 · KURA
• Capricor Therapeutics (CAPR) Q1 2026: $36.8M Operating Expense Signals Full-Scale Launch Readiness Amid NS Pharma Standoff
  May 13, 2026 · CAPR
• CoinCheck Group (CNCK) Q4 2026: Institutional Revenue Mix Diversifies as 3iQ Adds $810M AUM
  May 13, 2026 · CNCK
• Double Down Interactive (DDI) Q1 2026: Direct-to-Consumer Revenue Jumps 44%, Accelerating Margin Expansion
  May 13, 2026 · DDI
• MaxSight (MXCT) Q1 2026: OpEx Drops $7M, Unlocking Cash Burn Flexibility Amid SPL Portfolio Stability
  May 13, 2026 · MXCT
• GrowGeneration (GRWG) Q1 2026: Proprietary Brand Penetration Hits 37% as Store Closures Drive Leaner Growth
  May 13, 2026 · GRWG
• Spectral AI (MDAI) Q1 2026: $31.7M BARDA Acceleration Anchors DeepView Commercialization Timeline
  May 13, 2026 · MDAI
• Oklo (OKLO) Q1 2026: $2.5B War Chest Fuels Multi-Asset Nuclear Deployment Surge
  May 13, 2026 · OKLO
• Fold (FLD) Q1 2026: Transaction Volumes Down 31% as Bitcoin Drawdown Tests Platform Scale
  May 13, 2026 · FLD
• Consolidated Water (CWCO) Q1 2026: Manufacturing Revenue Drops 76% as Weather and Order Timing Reshape Segment Mix
  May 13, 2026 · CWCO
• Trisalis Life Sciences (TLSI) Q1 2026: PEDD Study Delivers $7,700 Per Patient Cost Avoidance, Driving Platform Validation
  May 13, 2026 · TLSI
• Transact Technologies (TACT) Q1 2026: Recurring FST Revenue Jumps 26% as Software Monetization Accelerates
  May 13, 2026 · TACT
• Astronics (ATRO) Q1 2026: Backlog Hits $734M as Broad-Based Demand Lifts Guidance
  May 13, 2026 · ATRO
• Nyxoah (NYXH) Q1 2026: U.S. Revenue Jumps 25% as Genio Adoption Accelerates
  May 13, 2026 · NYXH
• OptimizeRx (OPRX) Q1 2026: DAP Subscription Revenue Jumps 45% as Platform Model Accelerates
  May 13, 2026 · OPRX
• NeuroPace (NPCE) Q1 2026: RNS System Grows 20% as AI Roadmap, IGE Expansion Drive Guidance Lift
  May 13, 2026 · NPCE
• KRMN Q1 2026: Backlog Surges 61% as Multi-Year Defense Commitments Expand Visibility
  May 13, 2026 · KRMN
• TIGO Q1 2026: Colombia Acquisition Lifts Service Revenue 45%, Margin Expansion in Focus
  May 13, 2026 · TIGO
• Allot (ALLT) Q1 2026: CCAS Revenue Jumps 59%, Recurring Base Hits 67% of Total
  May 13, 2026 · ALLT
• Telebio (TELA) Q1 2026: 41% International Surge Validates Commercial Reset and Portfolio Expansion
  May 13, 2026 · TELA
• NextPower (NXT) Q4 2026: Non-Tracker Revenue Set to Jump 40% as Platform Expansion Accelerates
  May 13, 2026 · NXT
• Resideo (REZI) Q1 2026: ADI Transformation and 12% E-Commerce Growth Drive Strategic Separation Momentum
  May 13, 2026 · REZI
• Camtek (CAMT) Q1 2026: AI-Driven Orders to Lift H2 Revenue Over 25%
  May 13, 2026 · CAMT
• AudioEye (AEYE) Q1 2026: ARR Climbs 12% as Regulatory Tailwinds and AI Product Expansion Drive Momentum
  May 13, 2026 · AEYE
• 3M (MMM) Q1 2026: Order Backlog Climbs 35%, Fueling Growth Acceleration Narrative
  May 13, 2026 · MMM
• PAYS Q1 2026: Patient Affordability Surges 82%, Overtakes Plasma as Top Revenue Driver
  May 13, 2026 · PAYS
• Mobile Infrastructure (BEEP) Q1 2026: Same Location NOI Rises 4.4% as Asset Rotation Tops $30M
  May 13, 2026 · BEEP
• EVLV Q1 2026: 45% Revenue Surge Anchored by 64% Purchase Deal Mix Shift
  May 13, 2026 · EVLV
• IceCure Medical (ICCM) Q1 2026: North America Sales Surge 84% as FDA Clearance Unlocks Adoption
  May 13, 2026 · ICCM
• HireQuest (HQI) Q1 2026: Commercial Segment Rises as System-Wide Sales Near Flat Ex-Divestiture
  May 13, 2026 · HQI
• HUYA (HUYA) Q1 2026: Game-Related Revenue Jumps 69% as Platform Mix Shifts Beyond Live Streaming
  May 13, 2026 · HUYA
• Petrobras (PBR) Q1 2026: Oil Output Jumps 30% as Pre-Salt Expansion Accelerates
  May 13, 2026 · PBR
• Ovintiv (OVV) Q1 2026: Net Debt Falls Below $3.3B as Portfolio Depth and Cost Leadership Drive Strategic Flexibility
  May 13, 2026 · OVV
• Gold Resource (GORO) Q1 2026: Net Income Returns After Five Years, Merger Targets >100K Ounce Run Rate
  May 13, 2026 · GORO
• Arteris (AIP) Q1 2026: ACV Plus Royalties Up 39% as Data Center and Cybersecurity Drive Mix Shift
  May 13, 2026 · AIP